MEOBF
Price
$0.96
Change
-$0.00 (-0.00%)
Updated
Jun 23 closing price
Capitalization
2.13B
31 days until earnings call
NDTP
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Jul 21 closing price
Capitalization
9.76M
Interact to see
Advertisement

MEOBF vs NDTP

Header iconMEOBF vs NDTP Comparison
Open Charts MEOBF vs NDTPBanner chart's image
Mesoblast
Price$0.96
Change-$0.00 (-0.00%)
Volume$1K
Capitalization2.13B
NDT Pharmaceuticals
Price$0.06
Change+$0.01 (+20.00%)
Volume$12.53K
Capitalization9.76M
MEOBF vs NDTP Comparison Chart in %
Loading...
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEOBF vs. NDTP commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEOBF is a Hold and NDTP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (MEOBF: $0.96 vs. NDTP: $0.06)
Brand notoriety: MEOBF and NDTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEOBF: 108% vs. NDTP: 219%
Market capitalization -- MEOBF: $2.13B vs. NDTP: $9.76M
MEOBF [@Biotechnology] is valued at $2.13B. NDTP’s [@Biotechnology] market capitalization is $9.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEOBF’s FA Score shows that 0 FA rating(s) are green whileNDTP’s FA Score has 1 green FA rating(s).

  • MEOBF’s FA Score: 0 green, 5 red.
  • NDTP’s FA Score: 1 green, 4 red.
According to our system of comparison, NDTP is a better buy in the long-term than MEOBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEOBF’s TA Score shows that 4 TA indicator(s) are bullish while NDTP’s TA Score has 2 bullish TA indicator(s).

  • MEOBF’s TA Score: 4 bullish, 1 bearish.
  • NDTP’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, MEOBF is a better buy in the short-term than NDTP.

Price Growth

MEOBF (@Biotechnology) experienced а 0.00% price change this week, while NDTP (@Biotechnology) price change was +17.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

MEOBF is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEOBF($2.13B) has a higher market cap than NDTP($9.76M). NDTP YTD gains are higher at: 15.094 vs. MEOBF (-56.136).
MEOBFNDTPMEOBF / NDTP
Capitalization2.13B9.76M21,803%
EBITDA-77.78MN/A-
Gain YTD-56.13615.094-372%
P/E RatioN/AN/A-
Revenue5.67MN/A-
Total Cash37.7MN/A-
Total Debt126MN/A-
FUNDAMENTALS RATINGS
MEOBF vs NDTP: Fundamental Ratings
MEOBF
NDTP
OUTLOOK RATING
1..100
4349
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
6597
P/E GROWTH RATING
1..100
58100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NDTP's Valuation (5) in the null industry is significantly better than the same rating for MEOBF (88). This means that NDTP’s stock grew significantly faster than MEOBF’s over the last 12 months.

NDTP's Profit vs Risk Rating (100) in the null industry is in the same range as MEOBF (100). This means that NDTP’s stock grew similarly to MEOBF’s over the last 12 months.

MEOBF's SMR Rating (95) in the null industry is in the same range as NDTP (100). This means that MEOBF’s stock grew similarly to NDTP’s over the last 12 months.

MEOBF's Price Growth Rating (65) in the null industry is in the same range as NDTP (97). This means that MEOBF’s stock grew similarly to NDTP’s over the last 12 months.

MEOBF's P/E Growth Rating (58) in the null industry is somewhat better than the same rating for NDTP (100). This means that MEOBF’s stock grew somewhat faster than NDTP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEOBFNDTP
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
29%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
45%
Momentum
ODDS (%)
Bullish Trend 2 days ago
41%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
47%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
Bullish Trend 2 days ago
54%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMYSX9.840.01
+0.10%
Russell Inv Multi-Strategy Income S
PQIRX26.60N/A
N/A
Victory Pioneer Equity Income R
SEKIX21.18-0.08
-0.38%
DWS Emerging Markets Equity Inst
RIGEX43.58-0.19
-0.43%
American Funds Intl Gr and Inc R4
RIVDX19.37-0.15
-0.77%
American Funds International Vntg R-2

MEOBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEOBF has been loosely correlated with SPHDF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MEOBF jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEOBF
1D Price
Change %
MEOBF100%
N/A
SPHDF - MEOBF
50%
Loosely correlated
N/A
AVTX - MEOBF
46%
Loosely correlated
+0.90%
COGT - MEOBF
39%
Loosely correlated
-0.98%
MESO - MEOBF
26%
Poorly correlated
-3.65%
KROS - MEOBF
26%
Poorly correlated
+0.56%
More

NDTP and

Correlation & Price change

A.I.dvisor tells us that NDTP and MAIA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDTP and MAIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDTP
1D Price
Change %
NDTP100%
N/A
MAIA - NDTP
21%
Poorly correlated
-0.58%
MMIRF - NDTP
11%
Poorly correlated
N/A
MBXBF - NDTP
7%
Poorly correlated
N/A
NGENF - NDTP
6%
Poorly correlated
-4.44%
MEOBF - NDTP
4%
Poorly correlated
N/A
More